FAYRUS CAP. 50/3/300 MG. CAJA C/24 OSELTAMIVIR Janssen Pharmaceutical

Description

Janssen Pharmaceutical

PRINCIPIO ACTIVO: CEFTRIAXONA

Contiene: Lavanda/Manzanilla

un inhibidor selectivo de la tirosina quinasa de Bruton (BTK)

No administrar por vía intravenosa ni en bombas de infusión

FAYRUS CAP. 50/3/300 MG. CAJA C/24 OSELTAMIVIR Janssen PharmaceuticalPARACETAMOL 300. 00 MG AMANTADINA 50. 00 MG CLORFENAMINA 3. 00 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy